Cimpress NV (CMPR)
NASDAQ:CMPR
Top Page
Cimpress
(NASDAQ:CMPR)
Select Model
Select Model
Rating:60Neutral
Price Target:
$76.00
▼(-2.56% Downside)
Action:ReiteratedDate:04/01/26
Overall score reflects a tug-of-war between (1) balance-sheet risk and thin/volatile net profitability that constrain the financial-performance rating, and (2) a favorable valuation and a positive, guidance-raising earnings call. Technical indicators are broadly neutral and do not materially shift the outlook.
Positive Factors
Free Cash Flow Generation
Consistent positive free cash flow provides durable financial flexibility: it funds reinvestment in manufacturing and tech, supports debt paydown and buybacks, and cushions against cyclical dips. Over 2–6 months, sustained FCF growth enables execution of deleveraging and strategic investments without reliance on equity markets.
Negative Factors
Negative Equity & High Debt
Persistently negative equity and sizable debt materially constrain financial flexibility and raise downside risk. Negative equity complicates capital allocation, limits borrowing and strategic optionality, and heightens sensitivity to earnings volatility; deleveraging will be a multi-quarter structural priority to normalize the balance sheet.
Read all positive and negative factors
Positive Factors
Negative Factors
Free Cash Flow Generation
Consistent positive free cash flow provides durable financial flexibility: it funds reinvestment in manufacturing and tech, supports debt paydown and buybacks, and cushions against cyclical dips. Over 2–6 months, sustained FCF growth enables execution of deleveraging and strategic investments without reliance on equity markets.
Read all positive factors
Cimpress (CMPR) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$1.89B
Dividend YieldN/A
Average Volume (3M)175.12K
Price to Earnings (P/E)8.3
Beta (1Y)0.99
Revenue Growth3.65%
EPS Growth-76.96%
CountryUS
Employees15,000
SectorIndustrials
Sector Strength72
IndustryAdvertising Agencies
Share Statistics
EPS (TTM)1.95
Shares Outstanding24,285,192
10 Day Avg. Volume176,614
30 Day Avg. Volume175,120
Financial Highlights & Ratios
PEG Ratio-0.89
Price to Book (P/B)-2.08
Price to Sales (P/S)0.36
P/FCF Ratio8.36
Enterprise Value/Market Cap1.80
Enterprise Value/Revenue0.96
Enterprise Value/Gross Profit2.04
Enterprise Value/Ebitda9.54
Forecast
1Y Price Target
$95.00Price Target Upside21.79% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)3.3
Revenue Forecast (FY)$3.68B
Cimpress Business Overview & Revenue Model
Company Description
Cimpress plc provides various mass customization of printing and related products in North America, Europe, and internationally. The company operates through five segments: Vistaprint, PrintBrothers, The Print Group, National Pen, and All Other Bu...
How the Company Makes Money
Cimpress makes money primarily by selling customized physical products and related services through its online brands. (1) Product sales revenue: Customers place orders on Cimpress-owned e-commerce sites (e.g., Vista) for made-to-order items such ...
Cimpress Key Performance Indicators (KPIs)
Cimpress Earnings Call Summary
Earnings Call Date:Jan 29, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Apr 29, 2026
Earnings Call Sentiment Positive
The call presented a broadly positive picture: record quarterly revenue, raised full-year guidance across revenue, EBITDA and free cash flow, strong growth in elevated product categories, accelerating cross-enterprise fulfillment, progress on deleveraging, and continued strategic investments (manufacturing, shared tech, AI) with confirmed FY28 targets. Near-term negatives include margin compression from tariffs (~110 bps), higher CapEx and start-up costs, some regional/legacy-product softness (Europe and legacy business cards), and temporary hurricane-related costs. Overall, the positives (record revenue, guidance raise, EBITDA progress, XCF momentum, balance sheet improvement) materially outweigh the near-term headwinds.Positive Updates
Record Quarterly Revenue
Company exceeded $1,000,000,000 in quarterly revenue for the first time ever; Q2 revenue grew 11% on a reported basis and 4% on an organic constant-currency basis.
Negative Updates
Gross Margin Pressure from Tariffs
Gross margins declined ~110 basis points in Q2, largely driven by tariff impacts at National Pen (tariff costs and associated pricing offsets).
Read all updates
Q2-2026 Updates
Positive
Negative
Record Quarterly Revenue
Company exceeded $1,000,000,000 in quarterly revenue for the first time ever; Q2 revenue grew 11% on a reported basis and 4% on an organic constant-currency basis.
Read all positive updates
Company Guidance
Management raised FY26 guidance after a strong H1 and now expects revenue growth of 7–8% (3–4% organic constant‑currency), net income of at least $79.0M, adjusted EBITDA of at least $460.0M (up from $450.0M), operating cash flow ≈ $313.0M and adjusted free cash flow ≈ $145.0M (up from $140.0M). Key quarterly/half‑year metrics backing the raise include a record Q2 with >$1.0B revenue (Q2 reported +11%, organic cc +4%), H1 organic cc growth of 4% (above prior 2–3% guide), Q2 adjusted free cash flow of $124.0M (down $9.2M Y/Y), trailing‑12‑month net leverage of 2.97x at quarter end, $258.0M cash and $250.0M undrawn on the credit facility. Management reiterated FY28 targets of 4–6% organic cc growth, roughly $200.0M net income, adjusted EBITDA ≥ $600.0M, ~45% EBITDA→FCF conversion, and net leverage of ~2.5x at FY27 exit and below 2.0x at FY28 exit (subject to capital allocation).Cimpress Financial Statement Overview
Summary
Income Statement
56
Neutral
Balance Sheet
28
Negative
Cash Flow
67
Positive
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.56B | 3.40B | 3.29B | 3.08B | 2.89B | 2.58B |
| Gross Profit | 1.68B | 1.62B | 1.60B | 1.44B | 1.39B | 1.28B |
| EBITDA | 358.09M | 353.32M | 400.03M | 245.00M | 284.44M | 229.03M |
| Net Income | 23.43M | 14.95M | 173.68M | -185.98M | -54.33M | -85.23M |
Balance Sheet | ||||||
| Total Assets | 2.09B | 1.97B | 1.89B | 1.85B | 2.17B | 2.18B |
| Cash, Cash Equivalents and Short-Term Investments | 258.04M | 233.98M | 208.28M | 168.85M | 327.00M | 335.27M |
| Total Debt | 1.75B | 1.71B | 1.72B | 1.76B | 1.79B | 1.89B |
| Total Liabilities | 2.62B | 2.53B | 2.41B | 2.47B | 2.53B | 2.56B |
| Stockholders Equity | -530.73M | -583.49M | -550.15M | -623.14M | -494.92M | -449.37M |
Cash Flow | ||||||
| Free Cash Flow | 193.41M | 144.95M | 295.79M | 18.73M | 100.20M | 165.76M |
| Operating Cash Flow | 306.89M | 298.07M | 350.72M | 130.29M | 219.54M | 265.22M |
| Investing Cash Flow | -171.25M | -140.76M | -54.61M | -103.72M | -4.00M | -354.32M |
| Financing Cash Flow | -113.47M | -135.92M | -222.55M | -177.11M | -106.57M | 224.13M |
Cimpress Technical Analysis
Positive
78.00
Price Trends
73.47
Positive
72.69
Positive
65.44
Positive
Market Momentum
0.74
Negative
66.76
Neutral
60.91
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CMPR, the sentiment is Positive. The current price of 78 is above the 20-day moving average (MA) of 72.54, above the 50-day MA of 73.47, and above the 200-day MA of 65.44, indicating a bullish trend. The MACD of 0.74 indicates Negative momentum. The RSI at 66.76 is Neutral, neither overbought nor oversold. The STOCH value of 60.91 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CMPR.
Cimpress Risk Analysis
Cimpress disclosed 35 risk factors in its most recent earnings report. Cimpress reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Cimpress Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | $946.82M | 5.65 | 13.04% | ― | 0.32% | 69.78% | |
65 Neutral | $685.54M | -945.84 | -3.69% | ― | 31.28% | -22.05% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | $1.64B | 30.42 | 2.62% | ― | 5.70% | 97.88% | |
60 Neutral | $1.89B | 8.29 | -4.18% | ― | 3.65% | -76.96% | |
58 Neutral | $910.38M | -7.32 | -8.24% | 1.29% | 11.18% | ― |
* Industrials Sector Average
CMPR
Cimpress
78.00
33.50
75.28%
ZD
Ziff Davis
43.50
8.40
23.93%
CRTO
Criteo SA
18.51
-12.88
-41.03%
EEX
Emerald Expositions Events
4.60
0.94
25.68%
MNTN
MNTN, Inc Class A
9.28
-18.43
-66.51%
Cimpress Corporate Events
Business Operations and StrategyStock Buyback
Cimpress Board Authorizes New $200 Million Share Buyback
Positive
Mar 31, 2026
On March 25, 2026, Cimpress plc’s board authorized a new share repurchase program of up to $200 million of its outstanding ordinary shares, with no expiration date and flexibility to buy in the open market, via private deals, or through self...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.